Healthcare / Healthcare PlansSão Paulo
$1.59
-0.13 (-7.56%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $208.4M · quality 59.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$452M
P/E
79.5x
↑EV/EBITDA
3.0x
↓ROE
0.8%
↑Gross Margin
87.1%
↑Debt/Equity
1.37
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-9.9%
FCF CAGR
+0.5%
FCF margin
7.3%
FCF / Net income
9.78x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.43B · net income $10.7M · FCF $104.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.43B | $1.43B | $1.54B | $1.75B | $1.95B |
| Net Income | $10.7M | $10.7M | $6.6M | $-82.4M | $92.8M |
| EBITDA | $664.2M | $664.2M | $672.1M | $691.8M | $826.5M |
| EPS | 0.04 | 0.04 | 0.02 | -0.30 | 0.33 |
| Gross Margin | 87.1% | 87.1% | 83.5% | 78.9% | 77.2% |
| Operating Margin | 23.2% | 23.2% | 21.9% | 13.3% | 23.8% |
| Net Margin | 0.7% | 0.7% | 0.4% | -4.7% | 4.8% |
| Balance Sheet | |||||
| Debt/Equity | 1.37 | 1.37 | 1.47 | 1.76 | 1.68 |
| Current Ratio | 0.91 | 0.91 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $104.3M | $104.3M | $208.4M | $248.9M | $102.9M |
| Returns | |||||
| ROE | 0.8% | 0.8% | 0.5% | -6.5% | 6.9% |
| Valuation | |||||
| P/E | 79.50 | 79.50 | 64.54 | — | 18.97 |
| EV/EBITDA | 2.99 | 2.99 | 2.95 | 3.99 | 4.41 |
| P/B | 0.35 | 0.35 | 0.33 | 0.72 | 1.31 |
| Growth & Yield | |||||
| Revenue Growth | -7.5% | -7.5% | -11.9% | -10.3% | — |
| EPS Growth | 61.1% | 61.1% | 107.9% | -188.6% | — |
| Dividend Yield | 0.5% | 0.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
55.6%
EPS terminal req.
$0.14
Spread vs growth
5.5%
5Y implied EPS CAGR
35.4%
EPS terminal req.
$0.17
Spread vs growth
25.7%
10Y implied EPS CAGR
22.1%
EPS terminal req.
$0.27
Spread vs growth
39.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-25.9%
Start / end P/E
92.9x → 42.5x
EPS bridge
0.02 → 0.04
Residual
-33.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.